Posted on 358
ResearchAndMarkets.com’s offering.
This report on the global medical education market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030.
The report provides the revenue of the global medical education market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global medical education market during the forecast period.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global medical education market. These indices serve as valuable tools for existing market players as well as for entities intere
Factors Predict Survival After Coronary Angio in Postarrest Patients
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Perelman School of Medicine applications jump 21% as pandemic motivates future students
thedp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedp.com Daily Mail and Mail on Sunday newspapers.
Bookmark of this page has been deleted.
JMP Group Expands Life Sciences Investment Banking and Equity Research Platforms
JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Fedora Baloiu has joined JMP Securities as a managing director and co-head of biopharma corporate finance. Additionally, Silvan Tuerkcan and Gobind Singh, a director and vice president, respectively, have both joined JMP Securities as senior equity research analysts focused on the biotechnology sector. All three are based in the firm’s New York office.
In connection with these key additions to JMP Securities’ life sciences franchise, David Kellman, a managing director and head of healthcare investment banking, will also serve as co-head of biopharma corporate finance, while David Schechner, a managing director in the healthcare investment banking group, has been named head of biopharma mergers and acquisitions.